Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global immunochemistry market. The report provides market landscape, competitive landscape and market trends information on the immunochemistry market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include disease specific immunochemistry, drugs of abuse/toxicology, therapeutic drug monitoring, endocrinology tests, immunochemistry analyzers, immunochemistry rapid tests, organ function assays and specific proteins.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company share data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within immunochemistry market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Roche, Siemens Healthcare and Abbott Laboratories.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the immunochemistry market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the immunochemistry market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global immunochemistry market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction and Overview 8
2.1 GlobalData Report Guidance 8
3 Immunochemistry Overview 9
3.1 Disease Specific Immunochemistry 9
3.1.1 Allergy Blood Tests 9
3.1.2 Auto-immune Diseases 9
3.1.3 Cardiac Markers 9
3.1.4 Rheumatoid – Inflammatory Diseases Markers 9
3.1.5 Tumor Markers 9
3.2 Drugs of Abuse/Toxicology 10
3.2.1 Drugs of Abuse 10
3.2.2 Toxicology 10
3.3 Therapeutic Drug Monitoring 10
3.3.1 Antibiotic TDM/Antivirus TDM 10
3.3.2 Cardiovascular TDM 10
3.3.3 Central Nervous Systems TDM 10
3.3.4 Immunosuppressant TDM 11
3.4 Endocrinology Tests 11
3.4.1 Fertility or Pregnancy Hormones 11
3.4.2 Individual and Specified Hormones 11
3.4.3 Thyroid Function Hormones 11
3.5 Immunochemistry Analyzers 12
3.5.1 Chemiluminescence Analyzers 12
3.5.2 ELISA Instruments 12
3.5.3 Immunofluorescence Analyzers 12
3.5.4 Radioimmunoassay Analyzers 12
3.6 Immunochemistry Rapid Tests 12
3.7 Organ Function Assays 12
3.8 Specific Proteins 12
4 Immunochemistry: Global Market Characterization 13
4.1 Immunochemistry Market, Global, Revenue ($m), Historic, 2003–2010 13
4.2 Immunochemistry Market, Global, Revenue ($m), Forecast, 2010–2017 14
4.3 Immunochemistry, Market Dynamics 15
4.3.1 Trends 15
4.3.2 Market Drivers 16
4.3.3 Market Restraints 21
5 Immunochemistry Market: Segment Analysis 23
5.1 Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2003–2010 23
5.2 Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2010–2017 24
5.3 Disease Specific Immunochemistry, Market Dynamics 25
5.3.1 Market Drivers 25
5.3.2 Market Restraint: Bottlenecks in the Development of New Biomarkers Impeding the Development of Disease Specific Tests 25
5.4 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2003–2010 26
5.5 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2010–2017 27
5.6 Drugs of Abuse/Toxicology, Market Dynamics 28
5.6.1 Market Drivers 28
5.6.2 Market Restraint: Developments in Testing Not Able to Match the Pace at Which Illegal Drugs are Being Invented 29
5.7 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2003–2010 30
5.8 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2010–2017 31
5.9 Therapeutic Drug Monitoring, Market Dynamics 32
5.9.1 Market Driver: High Awareness among Physicians with Regard to Available Diagnostic Options 32
5.9.2 Market Restraint: Lack of Medical History Records of Individuals in Underdeveloped Countries adversely affecting use of Therapeutic Drug Monitoring 32
5.10 Endocrinology Tests Market, Global, Revenue ($m), Historic, 2003-2010 33
5.11 Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2010 – 2017 34
5.12 Endocrinology Tests, Market Dynamics 35
5.12.1 Market Driver: Surge in Reported Infertility Cases to Boost Testing Procedures 35
5.12.2 Market Restraint: Lack of Outreach about Options in Non-White Communities 35
5.13 Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2003–2010 36
5.14 Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2010–2017 37
5.15 Immunochemistry Analyzers, Market Dynamics 38
5.15.1 Market Driver: Accuracy offered by Analyzers is leading to their Higher Adoption 38
5.15.2 Market Restraint: Competition from Rapid Tests 38
5.16 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2003–2010 39
5.17 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2010–2017 40
5.18 Immunochemistry Rapid Tests, Market Dynamics 41
5.18.1 Market Driver: High Demand from Emergency Departments for Faster Testing Results 41
5.18.2 Market Restraint: Diagnostic Laboratories not in Favor of Rapid Tests Usage 41
5.19 Organ Function Assays Market, Global, Revenue ($m), Historic, 2003–2010 42
5.20 Organ Function Assays Market, Global, Revenue ($m), Forecast, 2010–2017 43
5.21 Organ Function Assays, Market Dynamics 44
5.21.1 Market Driver: Increasing Incidences of Liver and Kidney Diseases and Availability of Numerous Testing Options to Boost Market Growth 44
5.21.2 Market Restraint: High Cost Associated with the Overall Testing Discouraging People from Undergoing Tests 44
5.22 Specific Proteins Market, Global, Revenue ($m), Historic, 2003–2010 45
5.23 Specific Proteins Market, Global, Revenue ($m), Forecast, 2010–2017 46
5.24 Specific Proteins, Market Dynamics 47
5.24.1 Market Driver: Use of Specific Protein Tests as the First Step in Diagnostics Boosting their Demand 47
5.24.2 Market Restraint: Lack of Knowledge about Proteins that are Specific to Each Disorder Affecting Development of Tests 47
6 Global Immunochemistry Market, by Country, Revenue ($m), 2003–2017 48
6.1 Immunochemistry Market, the US, Revenue ($m), Historic, 2003–2010 48
6.2 Immunochemistry Market, the US, Revenue ($m), Forecast, 2010–2017 49
6.3 Immunochemistry Market, Canada, Revenue ($m), Historic, 2003 –2010 50
6.4 Immunochemistry Market, Canada, Revenue ($m), Forecast, 2010–2017 51
6.5 Immunochemistry Market, the UK, Revenue ($m), Historic, 2003–2010 52
6.6 Immunochemistry Market, the UK, Revenue ($m), Forecast, 2010–2017 53
6.7 Immunochemistry Market, Germany, Revenue ($m), Historic, 2003–2010 54
6.8 Immunochemistry Market, Germany, Revenue ($m), Forecast, 2010–2017 55
6.9 Immunochemistry Market, France, Revenue ($m), Historic, 2003–2010 56
6.10 Immunochemistry Market, France, Revenue ($m), Forecast, 2010–2017 57
6.11 Immunochemistry Market, Italy, Revenue ($m), Historic, 2003–2010 58
6.12 Immunochemistry Market, Italy, Revenue ($m), Forecast, 2010–2017 59
6.13 Immunochemistry Market, Spain, Revenue ($m), Historic, 2003–2010 60
6.14 Immunochemistry Market, Spain, Revenue ($m), Forecast, 2010–2017 61
6.15 Immunochemistry Market, Japan, Revenue ($m), Historic, 2003–2010 62
6.16 Immunochemistry Market, Japan, Revenue ($m), Forecast, 2010–2017 63
6.17 Immunochemistry Market, China, Revenue ($m), Historic, 2003–2010 64
6.18 Immunochemistry Market, China, Revenue ($m), Forecast, 2010–2017 65
6.19 Immunochemistry Market, India, Revenue ($m), Historic, 2003–2010 66
6.20 Immunochemistry Market, India, Revenue ($m), Forecast, 2010–2017 67
6.21 Immunochemistry Market, Australia, Revenue ($m), Historic, 2003–2010 68
6.22 Immunochemistry Market, Australia, Revenue ($m), Forecast, 2010–2017 69
6.23 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2003–2010 70
6.24 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2010–2017 71
7 Global Immunochemistry Market: Strategic Competitive Assessment 72
7.1 Immunochemistry: Key Market Participants 73
7.1.1 F. Hoffmann-La Roche Ltd. 73
7.1.2 Siemens Healthcare 77
7.1.3 Abbott Laboratories 81
7.1.4 Alere Inc. 85
8 Global Immunochemistry Market: Product Pipeline Assessment 88
8.1 Profiles of Promising Immunochemistry Products under Clinical Development 88
8.1.1 PROGENSA PCA3 Assay 88
8.1.2 CertNDx Bladder Cancer Assay 90
8.1.3 ADVIA Centaur CP System – UE3 Assay 92
8.1.4 Access BPHA Assay 92
8.1.5 Dimension Vista 1500 Intelligent Lab System CA 15-3 Assay 93
8.1.6 Next Generation FIT for Colorectal Cancer 93
8.1.7 RealTime mS9 Colorectal Cancer Test 93
8.1.8 TheraScreen K-RAS Mutation Test 94
8.1.9 AMIPredict 94
9 Global Immunochemistry Market: Strategic Deals Analysis 95
9.1 Key Acquisitions 95
9.1.1 Merck Completes the Acquisition of Millipore 95
9.1.2 Agilent Technologies Completes Acquisition of Varian 95
9.1.3 Inverness Medical Innovations (Alere Inc.) Acquires 78.13% Stake in Standard Diagnostics 96
9.1.4 Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S. 96
9.2 Key Partnership 97
9.2.1 Abbott Laboratories Enters Into an Agreement with GlaxoSmithKline 97
10 Appendix 98
10.1 Definitions 99
10.1.1 Immunochemistry 99
10.2 Acronyms 102
10.3 Sources 104
10.4 Research Methodology 104
10.5 Primary Research 105
10.6 Models 105
10.7 Forecasts 105
10.8 Expert Panels 106
10.9 GlobalData Consulting 106
10.10 Contact Us 106
10.11 Disclaimer 106
1.1 List of Tables
Table 1: Immunochemistry Market, Global, Revenue ($m), 2003–2010 13
Table 2: Immunochemistry Market, Global, Revenue ($m), 2010–2017 14
Table 3: Laboratory Acquisitions, the US, 2002–2008 17
Table 4: Immunochemistry Market, Global, PE/VC Investments, Volume, 2008-2010 19
Table 5: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2003–2010 23
Table 6: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2010–2017 24
Table 7: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2003–2010 26
Table 8: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2010–2017 27
Table 9: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2003–2010 30
Table 10: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2010–2017 31
Table 11: Endocrinology Tests Market, Global, Revenue ($m), 2003–2010 33
Table 12: Endocrinology Tests Market, Global, Revenue ($m), 2010–2017 34
Table 13: Immunochemistry Analyzers Market, Global, Revenue ($m), 2003–2010 36
Table 14: Immunochemistry Analyzers Market, Global, Revenue ($m), 2010–2017 37
Table 15: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 39
Table 16: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 40
Table 17: Organ Function Assays Market, Global, Revenue ($m), 2003–2010 42
Table 18: Organ Function Assays Market, Global, Revenue ($m), 2010–2017 43
Table 19: Specific Proteins Market, Global, Revenue ($m), 2003–2010 45
Table 20: Specific Proteins Market, Global, Revenue ($m), 2010–2017 46
Table 21: Immunochemistry Market, the US, Revenue ($m), 2003–2010 48
Table 22: Immunochemistry Market, the US, Revenue ($m), 2010–2017 49
Table 23: Immunochemistry Market, Canada, Revenue ($m), 2003–2010 50
Table 24: Immunochemistry Market, Canada, Revenue ($m), 2010–2017 51
Table 25: Immunochemistry Market, the UK, Revenue ($m), 2003–2010 52
Table 26: Immunochemistry Market, the UK, Revenue ($m), 2010–2017 53
Table 27: Immunochemistry Market, Germany, Revenue ($m), 2003–2010 54
Table 28: Immunochemistry Market, Germany, Revenue ($m), 2010–2017 55
Table 29: Immunochemistry Market, France, Revenue ($m), 2003–2010 56
Table 30: Immunochemistry Market, France, Revenue ($m), 2010–2017 57
Table 31: Immunochemistry Market, Italy, Revenue ($m), 2003–2010 58
Table 32: Immunochemistry Market, Italy, Revenue ($m), 2010–2017 59
Table 33: Immunochemistry Market, Spain, Revenue ($m), 2003–2010 60
Table 34: Immunochemistry Market, Spain, Revenue ($m), 2010–2017 61
Table 35: Immunochemistry Market, Japan, Revenue ($m), 2003 – 2010 62
Table 36: Immunochemistry Market, Japan, Revenue ($m), 2010–2017 63
Table 37: Immunochemistry Market, China, Revenue ($m), 2003–2010 64
Table 38: Immunochemistry Market, China, Revenue ($m), 2010–2017 65
Table 39: Immunochemistry Market, India, Revenue ($m), 2003–2010 66
Table 40: Immunochemistry Market, India, Revenue ($m), 2010–2017 67
Table 41: Immunochemistry Market, Australia, Revenue ($m), 2003–2010 68
Table 42: Immunochemistry Market, Australia, Revenue ($m), 2010–2017 69
Table 43: Immunochemistry Market, Brazil, Revenue ($m), 2003–2010 70
Table 44: Immunochemistry Market, Brazil, Revenue ($m), 2010 – 2017 71
Table 45: Immunochemistry Market, Global, Company Shares by Revenues ($m), 2009 72
Table 46: Immunochemistry Portfolio, F. Hoffmann-La Roche Ltd., 2011 73
Table 47: Immunochemistry Pipeline Portfolio, F. Hoffmann-La Roche Ltd., 2011 74
Table 48: Immunochemistry Portfolio, Siemens Healthcare, 2011 77
Table 49: Immunochemistry Pipeline Portfolio, Siemens Healthcare, 2011 78
Table 50: Immunochemistry Portfolio, Abbott Laboratories, 2010 81
Table 51: Immunochemistry Pipeline Portfolio, Abbott Laboratories, 2010 81
Table 52: Immunochemistry Portfolio, Alere Inc., 2011 85
Table 53: Immunochemistry Pipeline Portfolio, Alere Inc., 2011 85
Table 54: PROGENSA PCA3 Assay , Product Status, 2011 88
Table 55: PROGENSA PCA3 Assay – Molecular Urine Tests for Prostate Cancer 88
Table 56: PROGENSA PCA3 Assay – Clinical Evaluation of the PROGENSA PCA3 Assay in Men With a Previous Negative Biopsy Result 89
Table 57: CertNDx Bladder Cancer Assay, Product Status, 2011 90
Table 58: CertNDx Bladder Cancer Assay – Phase III Study of Bladder Cancer Recurrence Surveillance 90
Table 59: CertNDx Bladder Cancer Assay – A Study On ADAM 12 Cleaving Extracellular Matrix Proteins and Correlate With Cancer Status and Stage 91
Table 60: ADVIA Centaur CP System – UE3 Assay, Product Status, 2011 92
Table 61: Access BPHA Assay, Product Status, 2011 92
Table 62: Dimension Vista 1500 Intelligent Lab System CA 15-3 Assay, Product Status, 2011 93
Table 63: Next Generation FIT for Colorectal Cancer, Product Status, 2011 93
Table 64: RealTime mS9 Colorectal Cancer Test, Product Status, 2011 93
Table 65: TheraScreen K-RAS Mutation Test, Product Status, 2011 94
Table 66: AMIPredict, Product Status, 2011 94
1.2 List of Figures
Figure 1: Immunochemistry Market, Global, Revenue ($m), 2003–2010 13
Figure 2: Immunochemistry Market, Global, Revenue ($m), 2010–2017 14
Figure 3: Laboratory Acquisitions, the US, 2002–2008 16
Figure 4: Immunochemistry Market, Global, PE/VC Investments, Volume, 2008-2010 19
Figure 5: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2003–2010 23
Figure 6: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2010–2017 24
Figure 7: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2003–2010 26
Figure 8: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2010–2017 27
Figure 9: Drug Tests, Olympics, 2000–2008 28
Figure 10: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2003–2010 30
Figure 11: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2010–2017 31
Figure 12: Endocrinology Tests Market, Global, Revenue ($m), 2003–2010 33
Figure 13: Endocrinology Tests Market, Global, Revenue ($m), 2010–2017 34
Figure 14: Immunochemistry Analyzers Market, Global, Revenue ($m), 2003–2010 36
Figure 15: Immunochemistry Analyzers Market, Global, Revenue ($m), 2010–2017 37
Figure 16: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 39
Figure 17: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 40
Figure 18: Organ Function Assays Market, Global, Revenue ($m), 2003–2010 42
Figure 19: Organ Function Assays Market, Global, Revenue ($m), 2010–2017 43
Figure 20: Specific Proteins Market, Global, Revenue ($m), 2003–2010 45
Figure 21: Specific Proteins Market, Global, Revenue ($m), 2010–2017 46
Figure 22: Immunochemistry Market, the US, Revenue ($m), 2003–2010 48
Figure 23: Immunochemistry Market, the US, Revenue ($m), 2010–2017 49
Figure 24: Immunochemistry Market, Canada, Revenue ($m), 2003–2010 50
Figure 25: Immunochemistry Market, Canada, Revenue ($m), 2010–2017 51
Figure 26: Immunochemistry Market, the UK, Revenue ($m), 2003–2010 52
Figure 27: Immunochemistry Market, the UK, Revenue ($m), 2010–2017 53
Figure 28: Immunochemistry Market, Germany, Revenue ($m), 2003–2010 54
Figure 29: Immunochemistry Market, Germany, Revenue ($m), 2010–2017 55
Figure 30: Immunochemistry Market, France, Revenue ($m), 2003–2010 56
Figure 31: Immunochemistry Market, France, Revenue ($m), 2010–2017 57
Figure 32: Immunochemistry Market, Italy, Revenue ($m), 2003–2010 58
Figure 33: Immunochemistry Market, Italy, Revenue ($m), 2010–2017 59
Figure 34: Immunochemistry Market, Spain, Revenue ($m), 2003–2010 60
Figure 35: Immunochemistry Market, Spain, Revenue ($m), 2010–2017 61
Figure 36: Immunochemistry Market, Japan, Revenue ($m), 2003 – 2010 62
Figure 37: Immunochemistry Market, Japan, Revenue ($m), 2010–2017 63
Figure 38: Immunochemistry Market, China, Revenue ($m), 2003–2010 64
Figure 39: Immunochemistry Market, China, Revenue ($m), 2010–2017 65
Figure 40: Immunochemistry Market, India, Revenue ($m), 2003–2010 66
Figure 41: Immunochemistry Market, India, Revenue ($m), 2010–2017 67
Figure 42: Immunochemistry Market, Australia, Revenue ($m), 2003–2010 68
Figure 43: Immunochemistry Market, Australia, Revenue ($m), 2010–2017 69
Figure 44: Immunochemistry Market, Brazil, Revenue ($m), 2003–2010 70
Figure 45: Immunochemistry Market, Brazil, Revenue ($m), 2010 – 2017 71
Figure 46: Immunochemistry Market, Global, Company Shares (%), 2009 72
Figure 47: F. Hoffmann-La Roche Ltd, SWOT Analysis 75
Figure 48: Siemens Healthcare, SWOT Analysis 79
Figure 49: Abbott Laboratories, SWOT Analysis 83
Figure 50: Alere Inc., SWOT Analysis 86F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Alere Inc.
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article